FGBIP
First Guaranty Bancshares, Inc.
$20.49
0.00%
$337.4M
No data for this timeframe.
Vol
Market Cap$337.4M
Cap SizeSmall Cap
SEC Reports5
Exchange Nasdaq·Sector Savings Institution, Federally Chartered·Inc. LA·CIK 0001408534·Prev Close $20.49
Recent Activity
Jun 4, 2026
SEC
First Guaranty Bancshares reported the declaration of a $0.01 per share quarterly common dividend, payable on June 30, 2
8-K — Impact 2/10
May 7, 2026
SEC
First Guaranty Bancshares reported Q1 2026 net income of $2.7M ($0.14 EPS) vs a loss of $6.2M ($0.54 loss) a year ago, d
8-K — Impact 5/10
May 5, 2026
SEC
First Guaranty Bancshares repurchased three properties from an insider-owned entity for $14.77 million, simultaneously t
8-K — Impact 3/10
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 3 neutral. Avg impact: 3.6/10.
NEUTRAL
8-K
2/10
First Guaranty Bancshares reported the declaration of a $0.01 per share quarterly common dividend, p
Jun 4, 2026
MIXED
8-K
5/10
First Guaranty Bancshares reported Q1 2026 net income of $2.7M ($0.14 EPS) vs a loss of $6.2M ($0.54
May 7, 2026
NEUTRAL
8-K
3/10
First Guaranty Bancshares repurchased three properties from an insider-owned entity for $14.77 milli
May 5, 2026
MIXED
8-K
5/10
First Guaranty Bancshares reported Q1 2026 net income of $2.7M vs a loss of $6.2M a year ago, driven
Apr 27, 2026
NEUTRAL
8-K
3/10
First Guaranty Bancshares, Inc. appointed Betsy K. Hood to its Board of Directors on April 16, 2026.
Apr 22, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.